aTyr Pharma ATYR Finance Lease Liabilities (Total)
Finance Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.
The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about aTyr Pharma's finance lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is aTyr Pharma's finance lease liabilities (total)?
- aTyr Pharma (ATYR) reported finance lease liabilities (total) of $747K in Q1 2026.
- How has aTyr Pharma's finance lease liabilities (total) changed year-over-year?
- aTyr Pharma's finance lease liabilities (total) decreased by 42.4% year-over-year, from $1.3M to $747K.
- What is the long-term trend for aTyr Pharma's finance lease liabilities (total)?
- Over 3 years (2022 to 2025), aTyr Pharma's finance lease liabilities (total) has grown at a -11.2% compound annual growth rate (CAGR), from $1.27M to $889K.
- What does finance lease liabilities (total) mean?
- Finance lease liabilities (total) represent the aggregate present value of all future lease payments for assets where the company assumes substantially all risks and rewards of ownership. This metric reflects the long-term debt-like burden associated with financing infrastructure or equipment through leases. It is a key component of the company's total leverage profile.